AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients

Abstract Adipocyte enhancer binding protein 1 (AEBP1) is a transcriptional repressor that plays a critical role in regulating adipogenesis. Recent studies have indicated that AEBP1 might function as a candidate oncogene and is overexpressed in several human malignancies. However, the role of AEBP1 i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun-yan Liu, Lei Jiang, Jia-jia Liu, Tao He, You-hong Cui, Feng Qian, Pei-wu Yu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0384e16df8614026973a88bce6d44690
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0384e16df8614026973a88bce6d44690
record_format dspace
spelling oai:doaj.org-article:0384e16df8614026973a88bce6d446902021-12-02T15:08:43ZAEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients10.1038/s41598-018-29878-62045-2322https://doaj.org/article/0384e16df8614026973a88bce6d446902018-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29878-6https://doaj.org/toc/2045-2322Abstract Adipocyte enhancer binding protein 1 (AEBP1) is a transcriptional repressor that plays a critical role in regulating adipogenesis. Recent studies have indicated that AEBP1 might function as a candidate oncogene and is overexpressed in several human malignancies. However, the role of AEBP1 in gastric cancer (GC) remains largely unknown. This study aimed to investigate the expression pattern, prognostic significance and biological function of AEBP1 in human gastric cancer and to explore the underlying mechanism. We found that both the mRNA and protein levels of AEBP1 were significantly increased in human GC tissues. Elevated AEBP1 expression was significantly correlated with poor overall survival in patients with both early-stage (Tumor, Node, Metastases (TNM) TNM I and II) and late-stage (TNM III and IV) GC. Silencing AEBP1 markedly suppressed the proliferation, migration, invasion, metastasis and epithelial-mesenchymal transition of GC cells. Moreover, we demonstrated that knockdown of AEBP1 in GC cells led to inhibition of the NF-κB pathway by hampering the degradation of IκBα. Thus, AEBP1 might be served as a promising prognostic indicator and a potential therapeutic target in human GC.Jun-yan LiuLei JiangJia-jia LiuTao HeYou-hong CuiFeng QianPei-wu YuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jun-yan Liu
Lei Jiang
Jia-jia Liu
Tao He
You-hong Cui
Feng Qian
Pei-wu Yu
AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
description Abstract Adipocyte enhancer binding protein 1 (AEBP1) is a transcriptional repressor that plays a critical role in regulating adipogenesis. Recent studies have indicated that AEBP1 might function as a candidate oncogene and is overexpressed in several human malignancies. However, the role of AEBP1 in gastric cancer (GC) remains largely unknown. This study aimed to investigate the expression pattern, prognostic significance and biological function of AEBP1 in human gastric cancer and to explore the underlying mechanism. We found that both the mRNA and protein levels of AEBP1 were significantly increased in human GC tissues. Elevated AEBP1 expression was significantly correlated with poor overall survival in patients with both early-stage (Tumor, Node, Metastases (TNM) TNM I and II) and late-stage (TNM III and IV) GC. Silencing AEBP1 markedly suppressed the proliferation, migration, invasion, metastasis and epithelial-mesenchymal transition of GC cells. Moreover, we demonstrated that knockdown of AEBP1 in GC cells led to inhibition of the NF-κB pathway by hampering the degradation of IκBα. Thus, AEBP1 might be served as a promising prognostic indicator and a potential therapeutic target in human GC.
format article
author Jun-yan Liu
Lei Jiang
Jia-jia Liu
Tao He
You-hong Cui
Feng Qian
Pei-wu Yu
author_facet Jun-yan Liu
Lei Jiang
Jia-jia Liu
Tao He
You-hong Cui
Feng Qian
Pei-wu Yu
author_sort Jun-yan Liu
title AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
title_short AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
title_full AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
title_fullStr AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
title_full_unstemmed AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients
title_sort aebp1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the nf-κb pathway and predicts poor outcome of the patients
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/0384e16df8614026973a88bce6d44690
work_keys_str_mv AT junyanliu aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT leijiang aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT jiajialiu aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT taohe aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT youhongcui aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT fengqian aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
AT peiwuyu aebp1promotesepithelialmesenchymaltransitionofgastriccancercellsbyactivatingthenfkbpathwayandpredictspooroutcomeofthepatients
_version_ 1718387979805786112